UPDATE : Thursday, April 18, 2019
상단여백
‘No need to reduce number of drugs for triple-drug therapy to treat HIV’ by Kim Yun-mi 2019-04-18 15:20
Novartis’ new macular degeneration drug has to compete against colon cancer drug Avastin. Why? by Kim Yun-mi 2019-04-18 14:42
Immunotherapies’ liver cancer-treating effects confirmed in real-world studies by Kim Yun-mi 2019-04-15 14:29
Doctors skeptical about GSK’s new HIV drug despite FDA nod by Kim Yun-mi 2019-04-11 13:55
Saxenda no silver bullet for weight loss, doctors warn by Kim Yun-mi 2019-04-05 16:21
라인
[Reporter’s Notebook] Concerns over TB risk rise amid more use of TNF-α inhibitors by Kim Yun-mi 2019-03-29 17:21
Korean women more prone to infection with HPV-52, 58 by Kim Yun-mi 2019-03-28 15:03
[Special] Interleukin inhibitors Cosentyx, Taltz target psoriasis market by Kim Yun-mi 2019-03-26 14:56
Setback in search for Alzheimer’s drug: Biogen halts phase-3 aducanumab trials by Kim Yun-mi 2019-03-22 15:50
Korea closing in on tailored gene therapies to fight cancer by Kim Yun-mi 2019-03-21 11:47
라인
[Special] PCSK9 inhibitors aim to replace statin in cholesterol reduction by Kim Yun-mi 2019-03-18 15:49
Reimbursement for orphan drug Spinraza imminent by Kim Yun-mi 2019-03-18 12:02
Tecentriq becomes 1st immunotherapy OKed for specific breast cancer by Kim Yun-mi 2019-03-13 12:43
‘Pay more attention to lipid control in stroke patients’ by Kim Yun-mi 2019-03-12 11:32
When will NOAC reversal agents be available in Korea? by Kim Yun-mi 2019-03-07 15:52
라인
Biogen seeks gene therapy pipeline for rare eye disease by Kim Yun-mi 2019-03-06 14:41
Regulator expands XGEVA’s indication for use by multiple myeloma patients by Kim Yun-mi 2019-03-04 16:02
Korea’s drug exports hit record high in 2018, industry group says by Kim Yun-mi 2019-02-27 13:08
‘Heat-not-burn cigarettes as risky as traditional ones’ by Kim Yun-mi 2019-02-26 15:45
Korean Society of Cardiometabolic Syndrome goes international by Kim Yun-mi 2019-02-25 14:35
여백
여백
여백
Back to Top